Azenta (AZTA) Total Non-Current Liabilities (2010 - 2026)
Azenta (AZTA) recorded quarterly Total Non-Current Liabilities of $338.3 million in Q1 2026, down 2.82% quarter-over-quarter from $348.1 million in Q4 2025, and up 2.99% on a YoY basis from $328.5 million in Q1 2025.
Azenta (AZTA) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Azenta's Total Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $338.3 million for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities rose 2.99% year-over-year to $338.3 million; the TTM figure through Mar 2026 stood at $338.3 million (up 2.99% YoY), while the FY2025 annual figure was $348.1 million, changed N/A from the prior year.
- Total Non-Current Liabilities was $338.3 million for Q1 2026 at Azenta, down from $348.1 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $692.0 million in Q1 2022 to a low of $294.9 million in Q2 2022.
- Historically, Total Non-Current Liabilities has averaged $360.1 million across 5 years, with a median of $339.0 million in 2023.
- The sharpest annual moves came in 2022 and 2023: Total Non-Current Liabilities jumped 82.91% in 2022, then tumbled 48.96% in 2023.
- A 5-year view of Total Non-Current Liabilities shows it stood at $402.5 million in 2022, then slipped by 5.53% to $380.3 million in 2023, then dropped by 17.33% to $314.4 million in 2024, then increased by 10.74% to $348.1 million in 2025, then slipped by 2.82% to $338.3 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $338.3 million (Q1 2026), $348.1 million (Q4 2025), and $321.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 1.91 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 24.24 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 17.13 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 941.16 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 1.03 Bn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 8.65 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 3.98 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 2.10 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 12.54 Bn |
| 10 | Azenta | 1.06 Bn | 682.62 Mn | 62.04 Mn | 338.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 338.32 Mn |
| Dec 31, 2025 | 348.13 Mn |
| Sep 30, 2025 | 321.45 Mn |
| Jun 30, 2025 | 345.55 Mn |
| Mar 31, 2025 | 328.50 Mn |
| Dec 31, 2024 | 314.37 Mn |
| Sep 30, 2024 | 323.15 Mn |
| Jun 30, 2024 | 321.31 Mn |
| Mar 31, 2024 | 329.02 Mn |
| Dec 31, 2023 | 380.28 Mn |
| Sep 30, 2023 | 339.05 Mn |
| Jun 30, 2023 | 344.18 Mn |
| Mar 31, 2023 | 353.19 Mn |
| Dec 31, 2022 | 402.53 Mn |
| Sep 30, 2022 | 346.01 Mn |
| Jun 30, 2022 | 294.93 Mn |
| Mar 31, 2022 | 692.05 Mn |
| Dec 31, 2021 | 483.14 Mn |
| Sep 30, 2021 | 488.01 Mn |
| Jun 30, 2021 | 437.02 Mn |